Minireviews
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 6, 2024; 12(16): 2704-2712
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2704
Figure 1
Figure 1 Viral entry activates immune responses in host cells, which can further be target using therapeutic agents or immunotherapy strategies for treating coronavirus disease 2019 infections. ACE2: Angiotensin-converting enzyme 2; COVID-19: Coronavirus disease 2019; RBD; Receptor binding domain.